Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multifactorial Inheritance | 7 | 2024 | 1392 | 1.760 |
Why?
|
Coronary Artery Disease | 14 | 2024 | 6395 | 1.680 |
Why?
|
Hyperlipoproteinemia Type II | 5 | 2022 | 395 | 1.510 |
Why?
|
Plaque, Atherosclerotic | 3 | 2024 | 1530 | 1.150 |
Why?
|
Arabs | 2 | 2023 | 187 | 0.950 |
Why?
|
Genetic Predisposition to Disease | 12 | 2024 | 17912 | 0.840 |
Why?
|
Penetrance | 3 | 2020 | 388 | 0.740 |
Why?
|
Genome-Wide Association Study | 6 | 2024 | 12688 | 0.740 |
Why?
|
Receptors, LDL | 3 | 2013 | 488 | 0.720 |
Why?
|
Acute Coronary Syndrome | 2 | 2022 | 2190 | 0.620 |
Why?
|
Coronary Stenosis | 1 | 2023 | 794 | 0.590 |
Why?
|
Coronary Angiography | 3 | 2024 | 4472 | 0.530 |
Why?
|
Troponin I | 1 | 2020 | 651 | 0.520 |
Why?
|
Heredodegenerative Disorders, Nervous System | 1 | 2014 | 16 | 0.470 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2020 | 1313 | 0.440 |
Why?
|
Lipoproteins, LDL | 2 | 2013 | 642 | 0.430 |
Why?
|
Coronary Vasospasm | 2 | 2023 | 81 | 0.430 |
Why?
|
Therapies, Investigational | 1 | 2014 | 111 | 0.420 |
Why?
|
Urachus | 1 | 2012 | 18 | 0.410 |
Why?
|
Ubiquitins | 1 | 2014 | 366 | 0.410 |
Why?
|
Predictive Value of Tests | 3 | 2024 | 15262 | 0.410 |
Why?
|
Homozygote | 3 | 2013 | 1796 | 0.410 |
Why?
|
Cystadenocarcinoma, Mucinous | 1 | 2012 | 50 | 0.400 |
Why?
|
Cystadenoma, Mucinous | 1 | 2012 | 62 | 0.400 |
Why?
|
Pedigree | 10 | 2020 | 4589 | 0.400 |
Why?
|
Genetic Association Studies | 5 | 2015 | 2734 | 0.370 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 732 | 0.360 |
Why?
|
Heart Defects, Congenital | 4 | 2017 | 4696 | 0.350 |
Why?
|
Phenotype | 8 | 2024 | 16606 | 0.320 |
Why?
|
Disease Progression | 2 | 2024 | 13502 | 0.320 |
Why?
|
Myocardial Perfusion Imaging | 2 | 2023 | 575 | 0.300 |
Why?
|
Carotid Artery Diseases | 1 | 2013 | 877 | 0.280 |
Why?
|
Mutation | 6 | 2018 | 30045 | 0.280 |
Why?
|
Coronary Vessels | 3 | 2024 | 3096 | 0.280 |
Why?
|
Lebanon | 5 | 2018 | 245 | 0.270 |
Why?
|
Carcinoma in Situ | 1 | 2012 | 791 | 0.270 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8000 | 0.260 |
Why?
|
Risk Factors | 13 | 2024 | 74167 | 0.240 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 1 | 2022 | 75 | 0.210 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3447 | 0.210 |
Why?
|
Humans | 41 | 2024 | 761423 | 0.200 |
Why?
|
Genes, Dominant | 2 | 2014 | 863 | 0.180 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15498 | 0.180 |
Why?
|
Founder Effect | 1 | 2020 | 186 | 0.170 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2012 | 2223 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12143 | 0.170 |
Why?
|
Odds Ratio | 3 | 2020 | 9645 | 0.160 |
Why?
|
Case-Control Studies | 5 | 2022 | 22168 | 0.160 |
Why?
|
Sebaceous Glands | 1 | 2018 | 42 | 0.160 |
Why?
|
Heterozygote | 3 | 2020 | 2803 | 0.160 |
Why?
|
Eccrine Glands | 1 | 2018 | 52 | 0.160 |
Why?
|
Life Change Events | 1 | 2023 | 952 | 0.150 |
Why?
|
Pharmacogenetics | 1 | 2022 | 675 | 0.150 |
Why?
|
Anterior Eye Segment | 1 | 2018 | 143 | 0.150 |
Why?
|
Eye Diseases, Hereditary | 1 | 2018 | 122 | 0.150 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2024 | 1222 | 0.140 |
Why?
|
Middle Aged | 15 | 2024 | 220826 | 0.140 |
Why?
|
Hair Follicle | 1 | 2018 | 211 | 0.140 |
Why?
|
Codon, Nonsense | 2 | 2015 | 285 | 0.140 |
Why?
|
Costs and Cost Analysis | 1 | 2022 | 1668 | 0.130 |
Why?
|
Aortic Coarctation | 1 | 2018 | 282 | 0.130 |
Why?
|
Eye Abnormalities | 1 | 2018 | 242 | 0.130 |
Why?
|
Drug Discovery | 1 | 2024 | 1051 | 0.130 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 380 | 0.130 |
Why?
|
Genome | 1 | 2023 | 1740 | 0.130 |
Why?
|
Male | 21 | 2024 | 360736 | 0.120 |
Why?
|
Atherosclerosis | 2 | 2022 | 3407 | 0.120 |
Why?
|
Linear Models | 1 | 2024 | 5869 | 0.120 |
Why?
|
Myocardium | 2 | 2020 | 4725 | 0.120 |
Why?
|
Aged | 10 | 2024 | 169235 | 0.110 |
Why?
|
Prevalence | 3 | 2024 | 15717 | 0.110 |
Why?
|
Organic Cation Transport Proteins | 1 | 2013 | 61 | 0.110 |
Why?
|
Pyrazoles | 1 | 2023 | 2007 | 0.110 |
Why?
|
Consanguinity | 1 | 2015 | 456 | 0.110 |
Why?
|
Young Adult | 7 | 2021 | 59207 | 0.100 |
Why?
|
Muscular Diseases | 2 | 2013 | 553 | 0.100 |
Why?
|
Blood Component Removal | 1 | 2013 | 132 | 0.100 |
Why?
|
Life Style | 1 | 2024 | 3914 | 0.100 |
Why?
|
Genes, X-Linked | 1 | 2013 | 128 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 1 | 2020 | 1555 | 0.100 |
Why?
|
Hyperammonemia | 1 | 2013 | 76 | 0.100 |
Why?
|
Peer Review, Research | 1 | 2015 | 340 | 0.100 |
Why?
|
Carnitine | 1 | 2013 | 252 | 0.100 |
Why?
|
Forkhead Transcription Factors | 1 | 2018 | 1613 | 0.090 |
Why?
|
Fetal Heart | 1 | 2013 | 281 | 0.090 |
Why?
|
Nephrotic Syndrome | 1 | 2015 | 391 | 0.090 |
Why?
|
Genomics | 2 | 2024 | 5820 | 0.090 |
Why?
|
Female | 16 | 2024 | 392581 | 0.090 |
Why?
|
Genes, Recessive | 1 | 2013 | 628 | 0.090 |
Why?
|
Adult | 12 | 2024 | 221148 | 0.090 |
Why?
|
Molecular Typing | 1 | 2010 | 116 | 0.090 |
Why?
|
Protein Folding | 1 | 2014 | 870 | 0.090 |
Why?
|
Adolescent | 6 | 2020 | 88313 | 0.090 |
Why?
|
Chromosome Disorders | 1 | 2013 | 499 | 0.090 |
Why?
|
Purines | 2 | 2023 | 605 | 0.090 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2022 | 2751 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2578 | 0.080 |
Why?
|
Echocardiography | 2 | 2020 | 4991 | 0.080 |
Why?
|
Heart Failure | 1 | 2014 | 11674 | 0.080 |
Why?
|
Genotype | 2 | 2022 | 13009 | 0.080 |
Why?
|
Aneuploidy | 1 | 2013 | 551 | 0.080 |
Why?
|
Systems Biology | 1 | 2013 | 481 | 0.080 |
Why?
|
Qualitative Research | 2 | 2021 | 3023 | 0.080 |
Why?
|
DNA Mutational Analysis | 2 | 2015 | 4110 | 0.080 |
Why?
|
Risk | 1 | 2020 | 9612 | 0.080 |
Why?
|
Perception | 1 | 2015 | 1197 | 0.080 |
Why?
|
Cohort Studies | 4 | 2022 | 41446 | 0.080 |
Why?
|
Child | 6 | 2020 | 80162 | 0.070 |
Why?
|
Epigenomics | 1 | 2014 | 942 | 0.070 |
Why?
|
Apolipoproteins E | 1 | 2013 | 1443 | 0.070 |
Why?
|
Risk Assessment | 3 | 2024 | 23990 | 0.070 |
Why?
|
Syndrome | 2 | 2013 | 3268 | 0.070 |
Why?
|
DNA | 1 | 2021 | 7219 | 0.070 |
Why?
|
Point Mutation | 1 | 2013 | 1596 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2024 | 3244 | 0.070 |
Why?
|
Models, Cardiovascular | 1 | 2013 | 981 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2017 | 2220 | 0.070 |
Why?
|
Genome, Human | 1 | 2020 | 4425 | 0.070 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2013 | 829 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2024 | 4811 | 0.070 |
Why?
|
Body Mass Index | 1 | 2024 | 12951 | 0.070 |
Why?
|
Exons | 1 | 2012 | 2393 | 0.070 |
Why?
|
Hypertension | 2 | 2023 | 8542 | 0.060 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2416 | 0.060 |
Why?
|
Abnormalities, Multiple | 1 | 2013 | 1424 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 15941 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 26112 | 0.060 |
Why?
|
Algorithms | 1 | 2024 | 14026 | 0.060 |
Why?
|
Prognosis | 1 | 2024 | 29620 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2898 | 0.060 |
Why?
|
Hemodynamics | 1 | 2014 | 4168 | 0.050 |
Why?
|
Disease Management | 1 | 2014 | 2507 | 0.050 |
Why?
|
Models, Genetic | 1 | 2013 | 3446 | 0.050 |
Why?
|
Aortic Valve Stenosis | 1 | 2015 | 2009 | 0.050 |
Why?
|
Time Factors | 1 | 2024 | 39975 | 0.050 |
Why?
|
Prospective Studies | 2 | 2024 | 54415 | 0.050 |
Why?
|
Apolipoprotein A-I | 1 | 2023 | 299 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 12938 | 0.050 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2022 | 325 | 0.050 |
Why?
|
Students, Medical | 1 | 2015 | 1930 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2010 | 2382 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2013 | 1964 | 0.050 |
Why?
|
Alleles | 1 | 2012 | 6922 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6935 | 0.040 |
Why?
|
Genetic Testing | 1 | 2013 | 3538 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7389 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15838 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3429 | 0.040 |
Why?
|
Lipoprotein(a) | 1 | 2023 | 480 | 0.040 |
Why?
|
Mendelian Randomization Analysis | 1 | 2024 | 1008 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2023 | 1068 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7856 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3423 | 0.040 |
Why?
|
Child, Preschool | 3 | 2015 | 42254 | 0.030 |
Why?
|
Animals | 3 | 2024 | 168441 | 0.030 |
Why?
|
Age Factors | 1 | 2013 | 18400 | 0.030 |
Why?
|
NFATC Transcription Factors | 1 | 2018 | 389 | 0.030 |
Why?
|
Triglycerides | 1 | 2023 | 2460 | 0.030 |
Why?
|
Transcription Factors | 1 | 2015 | 12125 | 0.030 |
Why?
|
Achilles Tendon | 1 | 1997 | 180 | 0.030 |
Why?
|
Infant | 2 | 2013 | 36205 | 0.030 |
Why?
|
Diabetic Foot | 1 | 1997 | 380 | 0.030 |
Why?
|
Monocytes | 1 | 2022 | 2572 | 0.030 |
Why?
|
Base Sequence | 2 | 2015 | 12450 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21012 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2013 | 26212 | 0.030 |
Why?
|
HeLa Cells | 1 | 2018 | 3093 | 0.030 |
Why?
|
Self Report | 1 | 2023 | 3724 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2018 | 1302 | 0.020 |
Why?
|
Thinking | 1 | 2015 | 320 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2015 | 17644 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2024 | 12058 | 0.020 |
Why?
|
Primary Prevention | 1 | 2017 | 1186 | 0.020 |
Why?
|
Attitude | 1 | 2015 | 775 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2015 | 2382 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4278 | 0.020 |
Why?
|
Focus Groups | 1 | 2015 | 1413 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2013 | 1494 | 0.020 |
Why?
|
Career Choice | 1 | 2015 | 756 | 0.020 |
Why?
|
DNA Primers | 1 | 2013 | 2820 | 0.020 |
Why?
|
Schools, Medical | 1 | 2015 | 878 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14599 | 0.020 |
Why?
|
Exercise | 1 | 2024 | 5884 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6766 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12456 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6479 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6086 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2016 | 2752 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4741 | 0.010 |
Why?
|
Electrocardiography | 1 | 2015 | 6384 | 0.010 |
Why?
|
Genetic Variation | 1 | 2015 | 6581 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2018 | 80582 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13255 | 0.010 |
Why?
|
Pliability | 1 | 1997 | 58 | 0.010 |
Why?
|
Atrial Fibrillation | 1 | 2016 | 5127 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39117 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81509 | 0.010 |
Why?
|
Osteoarthritis | 1 | 1997 | 1060 | 0.010 |
Why?
|
Concepts
(198)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_